Literature DB >> 10914320

Captopril floating and/or bioadhesive tablets: design and release kinetics.

A O Nur1, J S Zhang.   

Abstract

Two viscosity grades of hydroxypropylmethylcellulose (HPMC 4000 and 15,000 cps) and Carbopol 934P were used to prepare captopril floating tablets. In vitro dissolution was carried out in simulated gastric fluid (enzyme free) at 37 degrees C +/- 0.1 degree C using the USP apparatus 2 basket method. Compared to conventional tablets, release of captopril from these floating tablets was apparently prolonged; as a result, a 24-hr controlled-release dosage form for captopril was achieved. Drug release best fit both the Higuchi model and the Korsmeyer and Peppas equation, followed by first-order kinetics. While tablet hardness and stirring rate had no or little effect on the release kinetics, tablets hardness was found to be a determining factor with regard to the buoyancy of the tablets.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10914320     DOI: 10.1081/ddc-100101323

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  15 in total

Review 1.  Floating drug delivery systems: a review.

Authors:  Shweta Arora; Javed Ali; Alka Ahuja; Roop K Khar; Sanjula Baboota
Journal:  AAPS PharmSciTech       Date:  2005-10-19       Impact factor: 3.246

2.  Development and evaluation of sustained release gastroretentive minimatrices for effective treatment of H. pylori infection.

Authors:  Atul C Badhan; Rajashree C Mashru; Punit P Shah; Arti R Thakkar; Nitin B Dobaria
Journal:  AAPS PharmSciTech       Date:  2009-04-21       Impact factor: 3.246

3.  Bioavailability enhancement and targeting of stomach tumors using gastro-retentive floating drug delivery system of curcumin--"a technical note".

Authors:  Neeta Gupta; Nidhi Aggarwal
Journal:  AAPS PharmSciTech       Date:  2008-07-04       Impact factor: 3.246

4.  Design of an interpolyelectrolyte gastroretentive matrix for the site-specific zero-order delivery of levodopa in Parkinson's disease.

Authors:  Ndidi C Ngwuluka; Yahya E Choonara; Girish Modi; Lisa C du Toit; Pradeep Kumar; Valence M K Ndesendo; Viness Pillay
Journal:  AAPS PharmSciTech       Date:  2013-03-15       Impact factor: 3.246

5.  Gastroretentive Matrix Tablets of Boswellia Oleogum Resin: Preparation, Optimization, In Vitro Evaluation, and Cytoprotective Effect on Indomethacin-Induced Gastric Ulcer in Rabbits.

Authors:  Rehab Mohammad Yusif; Irhan Ibrahim Abu Hashim; Elham Abdelmonem Mohamed; Farid Abd-Elreheim Badria
Journal:  AAPS PharmSciTech       Date:  2015-06-20       Impact factor: 3.246

6.  Effect of pH on sublingual absorption of oxycodone hydrochloride.

Authors:  Abeer M Al-Ghananeem; Ahmad H Malkawi; Peter A Crooks
Journal:  AAPS PharmSciTech       Date:  2006-03-10       Impact factor: 3.246

7.  Multiunit floating drug delivery system of rosiglitazone maleate: development, characterization, statistical optimization of drug release and in vivo evaluation.

Authors:  Madan Mohan Kamila; Nita Mondal; Lakshmi Kanta Ghosh; Bijan Kumar Gupta
Journal:  AAPS PharmSciTech       Date:  2009-07-02       Impact factor: 3.246

8.  Development and in vitro evaluation of an oral floating matrix tablet formulation of diltiazem hydrochloride.

Authors:  Manoj N Gambhire; Kshitij W Ambade; Sushma D Kurmi; Vilasrao J Kadam; Kisan R Jadhav
Journal:  AAPS PharmSciTech       Date:  2007-09-07       Impact factor: 3.246

9.  Formulation optimization of hydrodynamically balanced oral controlled release bioadhesive tablets of tramadol hydrochloride.

Authors:  Bhupinder Singh; Ashu Rani; Naveen Ahuja; Rishi Kapil
Journal:  Sci Pharm       Date:  2010-04-18

10.  New formulation of an old drug in hypertension treatment: the sustained release of captopril from cyclodextrin nanoparticles.

Authors:  Mariangela de Burgos M de Azevedo; Ljubica Tasic; Juliana Fattori; Fábio H S Rodrigues; Fabiana C Cantos; Leandro P Ribeiro; Vanice de Paula; Danielle Ianzer; Robson A S Santos
Journal:  Int J Nanomedicine       Date:  2011-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.